StockWatch
·
Pharmaceuticals
ESOP23 Jul 2026, 01:25 pm

Cipla Ltd Grants 24,709 Employee Stock Options and SARs

AI Summary

Cipla Ltd announced grants under its Employee Stock Option Scheme 2013-A (ESOS 2013-A) and Cipla Employee Stock Appreciation Rights Scheme 2021 (ESAR 2021). Under ESOS 2013-A, 5,530 stock options were granted with a 2-year vesting period and a 5-year exercise period from vesting. Under ESAR 2021, 19,179 Employee Stock Appreciation Rights were granted with a 3-year graded vesting and a 5-year exercise period from vesting. The exercise price for stock options is INR 2, and for ESARs is INR 2 per equity share. The company's board meeting, which commenced today, has concluded.

Key Highlights

  • Cipla Ltd has granted 5,530 stock options under ESOS 2013-A.
  • Cipla Ltd has granted 19,179 ESARs under ESAR 2021.
  • Both schemes have exercise prices of INR 2.
  • Vesting periods range from 2 to 3 years.
  • Exercise periods are 5 years from vesting.